In light of observing posttranslational modification of CXCR4 with ubiquitin in neuroblastoma cells we decided to examine what effect if any, treatment with the irreversible proteasome inhibitor lactacystin would have on surface expression of CXCR4. Here, CXCR4 is linked to neuroblastoma.